Institut Català de la Salut
[Dámaso E] Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d’Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Avinguda de la Gran Via de l’Hospitalet 199-203, L’Hospitalet de Llobregat, Barcelona, Spain. [González-Acosta M, Vargas-Parra G, Navarro M] Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d’Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Avinguda de la Gran Via de l’Hospitalet 199-203, L’Hospitalet de Llobregat, Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ramon Y Cajal T] Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Carrer de Sant Quintí 89, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2021-08-25T12:43:20Z
2021-08-25T12:43:20Z
2020-07-05
Síndrome de Lynch; Panell de gens del càncer; Epimutació
Síndrome de Lynch; Panel de genes del cáncer; Epimutación
Lynch syndrome; Cancer genes panel; Epimutation
The causal mechanism for cancer predisposition in Lynch-like syndrome (LLS) remains unknown. Our aim was to elucidate the constitutional basis of mismatch repair (MMR) deficiency in LLS patients throughout a comprehensive (epi)genetic analysis. One hundred and fifteen LLS patients harboring MMR-deficient tumors and no germline MMR mutations were included. Mutational analysis of 26 colorectal cancer (CRC)-associated genes was performed. Pathogenicity of MMR variants was assessed by splicing and multifactorial likelihood analyses. Genome-wide methylome analysis was performed by the Infinium Human Methylation 450K Bead Chip. The multigene panel analysis revealed the presence of two MMR gene truncating mutations not previously found. Of a total of 15 additional MMR variants identified, five -present in 6 unrelated individuals- were reclassified as pathogenic. In addition, 13 predicted deleterious variants in other CRC-predisposing genes were found in 12 probands. Methylome analysis detected one constitutional MLH1 epimutation, but no additional differentially methylated regions were identified in LLS compared to LS patients or cancer-free individuals. In conclusion, the use of an ad-hoc designed gene panel combined with pathogenicity assessment of variants allowed the identification of deleterious MMR mutations as well as new LLS candidate causal genes. Constitutional epimutations in non-LS-associated genes are not responsible for LLS.
This work was funded by the Spanish Ministry of Economy and Competitiveness and cofunded by FEDER funds -a way to build Europe- (grants SAF2012-33636, SAF2015-68016-R and SAF2016-80888-R), CIBERONC, RTICC Network (RD12/0036/0031 and RD12/0036/0008), the Spanish Association Against Cancer (AECC) (080253), the Government of Catalonia (grant 2014SGR338, 2017SGR1282 and PERIS SLT002/16/0037), Fundación Mutua Madrileña (grant AP114252013). We thank CERCA Programme for institutional support. ED was supported by a grant from the Spanish Ministry of Economy and Competitiveness. The AECC fellowship to MG-A. AF was supported by a grant from the Catalonian Health Department (SLT002/16/00409). FM was supported by CIBERONC. The Mexican National Council for Science and Technology (CONACyT) fellowship to GV.
Article
Versió publicada
Anglès
Aparell digestiu - Malalties - Aspectes genètics; Càncer - Prognosi; DISEASES::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Neoplastic Syndromes, Hereditary::Colorectal Neoplasms, Hereditary Nonpolyposis; PHENOMENA AND PROCESSES::Genetic Phenomena::Genotype::Genetic Predisposition to Disease; ENFERMEDADES::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::síndromes neoplásicos hereditarios::neoplasias colorrectales hereditarias sin poliposis; FENÓMENOS Y PROCESOS::fenómenos genéticos::genotipo::predisposición genética a la enfermedad
MDPI
Cancers;12(7)
https://www.mdpi.com/2072-6694/12/7/1799
info:eu-repo/grantAgreement/ES/1PN/2008-2011/SAF2012-33636
info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2015-68016-R
info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2016-80888-R
info:eu-repo/grantAgreement/ES/2PN/2008-2011/RD12%2F0036%2F0031
info:eu-repo/grantAgreement/ES/3PN/2008-2011/RD12%2F0036%2F0008
info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F0037
info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F00409
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/